Status:
SUSPENDED
Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes
Lead Sponsor:
Sun Yat-sen University
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
25-70 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.continuous subcutaneous insulin infusion combined with ros...
Eligibility Criteria
Inclusion
- newly diagnosed type 2 diabetes,
Exclusion
- received previous antihyperglycaemic therapy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00948324
Start Date
June 1 2008
End Date
December 1 2021
Last Update
October 3 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.